Bivalirudin in Current Practice
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference6 articles.
1. Developing drugs for use before, during and soon after percutaneous coronary intervention;Gargiulo;Exp Opin Pharmacother,2016
2. Clinical outcomes of bivalirudin for ischemic heart disease;Kong;Circulation,1999
3. Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: final report reanalysis of the Bivalirudin Angioplasty Study;Bittl;Am Heart J,2001
4. Comprehensive meta-analysis of safety and efficacy of bivalirudin versus heparin with or without routine glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndrome;Navarese;J Am Coll Cardiol Intv,2015
5. Effect of post-primary percutaneous coronary intervention bivalirudin infusion on acute stent thrombosis: meta-analysis of randomized controlled trials;Shah;J Am Coll Cardiol Intv,2016
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Periprocedural antithrombotic strategies in acute coronary syndromes undergoing percutaneous coronary intervention: Have we discarded bivalirudin too soon?;Cardiovascular Revascularization Medicine;2023-12
2. Reperfusion After Fibrinolytic Therapy (RAFT): An open-label, multi-centre, randomised controlled trial of bivalirudin versus heparin in rescue percutaneous coronary intervention;PLOS ONE;2021-10-26
3. Impact of sex on comparative outcomes of bivalirudin versus unfractionated heparin in patients with acute coronary syndromes undergoing invasive management: a pre-specified analysis of the MATRIX trial;EuroIntervention;2019-06
4. Post-Procedural Bivalirudin Infusion at Full or Low Regimen in Patients With Acute Coronary Syndrome;Journal of the American College of Cardiology;2019-02
5. Bivalirudin or Heparin in Patients Undergoing Invasive Management of Acute Coronary Syndromes;Journal of the American College of Cardiology;2018-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3